191 related articles for article (PubMed ID: 33240825)
1. Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant
Mukherjee S; Pradhan S; Ghosh S; Sundar S; Das S; Mukherjee B; Roy S
Front Cell Infect Microbiol; 2020; 10():595415. PubMed ID: 33240825
[TBL] [Abstract][Full Text] [Related]
2. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
[TBL] [Abstract][Full Text] [Related]
3. Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Das AK; Roy S
PLoS Negl Trop Dis; 2012; 6(12):e1987. PubMed ID: 23301108
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
[TBL] [Abstract][Full Text] [Related]
5. Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection.
Mukherjee B; Paul J; Mukherjee S; Mukhopadhyay R; Das S; Naskar K; Sundar S; Dujardin JC; Saha B; Roy S
J Immunol; 2015 Sep; 195(6):2731-42. PubMed ID: 26283478
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
Das P; Paik D; Naskar K; Chakraborti T
Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
[TBL] [Abstract][Full Text] [Related]
7. Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients.
Khanra S; Das S; Sarraf NR; Datta S; Das AK; Manna M; Roy S
Front Cell Infect Microbiol; 2022; 12():1021464. PubMed ID: 36405965
[TBL] [Abstract][Full Text] [Related]
8. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection.
Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S
Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276
[TBL] [Abstract][Full Text] [Related]
10. Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.
Mukherjee B; Mukhopadhyay R; Bannerjee B; Chowdhury S; Mukherjee S; Naskar K; Allam US; Chakravortty D; Sundar S; Dujardin JC; Roy S
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):E575-82. PubMed ID: 23341611
[TBL] [Abstract][Full Text] [Related]
11. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.
Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S
Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564
[TBL] [Abstract][Full Text] [Related]
12. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
[TBL] [Abstract][Full Text] [Related]
14. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
Murray HW
Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
[TBL] [Abstract][Full Text] [Related]
16. Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani.
Mukherjee B; Mukherjee K; Nanda P; Mukhopadhayay R; Ravichandiran V; Bhattacharyya SN; Roy S
Cytokine; 2021 Sep; 145():155245. PubMed ID: 32861564
[TBL] [Abstract][Full Text] [Related]
17. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.
Guha R; Das S; Ghosh J; Sundar S; Dujardin JC; Roy S
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2995. PubMed ID: 25032977
[TBL] [Abstract][Full Text] [Related]
18. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S
J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560
[TBL] [Abstract][Full Text] [Related]
19. Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog.
Baumann RJ; Hanson WL; McCann PP; Sjoerdsma A; Bitonti AJ
Antimicrob Agents Chemother; 1990 May; 34(5):722-7. PubMed ID: 2360812
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.
Berman JD; Hanson WL; Chapman WL; Alving CR; Lopez-Berestein G
Antimicrob Agents Chemother; 1986 Dec; 30(6):847-51. PubMed ID: 3813512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]